Evaluation of C-reactive protein as predictor of adverse prognosis in acute myocardial infarction after percutaneous coronary intervention: A systematic review and meta-analysis from 18,715 individuals

BACKGROUND: Proper prognostic biomarker is of great importance for clinical decision-making in patients with acute myocardial infarction (AMI) undergoing percutaneous coronary intervention (PCI). Although recently emerges plenty of novel inflammatory biomarkers, the canonical inflammatory mediator C...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Shijie, Jiang, Hongcheng, Dhuromsingh, Menaka, Dai, Lei, Jiang, Yue, Zeng, Hesong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9708737/
https://www.ncbi.nlm.nih.gov/pubmed/36465441
http://dx.doi.org/10.3389/fcvm.2022.1013501

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9708737/
https://www.ncbi.nlm.nih.gov/pubmed/36465441
http://dx.doi.org/10.3389/fcvm.2022.1013501

Ejemplares similares